The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target

The inhibition of tumor angiogenesis is one of the main challenges in cancer therapy. With the aim of developing monoclonal antibodies able to inhibit angiogenesis, we immunized mice with proliferating human umbilical vein endothelial cells. We generated a library of monoclonal antibodies able to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlandini, Maurizio, Galvagni, Federico, Bardelli, Monia, Rocchigiani, Marina, Lentucci, Claudia, Anselmi, Francesca, Zippo, Alessio, Bini, Luca, Oliviero, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058042/
https://www.ncbi.nlm.nih.gov/pubmed/24809468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058042/
https://www.ncbi.nlm.nih.gov/pubmed/24809468

Ejemplares similares